{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:09:26Z","timestamp":1767856166579,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00405-018-4866-y","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T08:05:35Z","timestamp":1515657935000},"page":"857-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Strengthening the case for gender-neutral and the nonavalent HPV vaccine"],"prefix":"10.1007","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-4032","authenticated-orcid":false,"given":"Justin M.","family":"Hintze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"issue":"1\u20132","key":"4866_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.virol.2013.07.015","volume":"445","author":"D Bzhalava","year":"2013","unstructured":"Bzhalava D, Guan P, Franceschi S, Dillner J, Clifford G (2013) A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 445(1\u20132):224\u2013231. https:\/\/doi.org\/10.1016\/j.virol.2013.07.015","journal-title":"Virology"},{"key":"4866_CR2","doi-asserted-by":"crossref","unstructured":"Viens LJ (2016) Human papillomavirus\u2013associated cancers\u2014United States, 2008\u20132012. MMWR Morbidity and mortality weekly report 65","DOI":"10.15585\/mmwr.mm6526a1"},{"issue":"1","key":"4866_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","volume":"401","author":"H-U Bernard","year":"2010","unstructured":"Bernard H-U, Burk RD, Chen Z, van Doorslaer K, Hausen Hz, de Villiers E-M (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401(1):70\u201379. https:\/\/doi.org\/10.1016\/j.virol.2010.02.002","journal-title":"Virology"},{"issue":"1","key":"4866_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-9378-4-8","volume":"4","author":"M Schiffman","year":"2009","unstructured":"Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Cancer 4(1):8. https:\/\/doi.org\/10.1186\/1750-9378-4-8","journal-title":"Infect Agents Cancer"},{"issue":"6","key":"4866_CR5","doi-asserted-by":"publisher","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","volume":"107","author":"M Saraiya","year":"2015","unstructured":"Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107(6):djv086. https:\/\/doi.org\/10.1093\/jnci\/djv086","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"4866_CR6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1349-7006.2007.00546.x","volume":"98","author":"M Narisawa-Saito","year":"2007","unstructured":"Narisawa-Saito M, Kiyono T (2007) Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 98(10):1505\u20131511. https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00546.x","journal-title":"Cancer Sci"},{"key":"4866_CR7","unstructured":"Cancer Trends No 33. HPV-associated cancers (2017). vol\u00a02017. National Cancer Registry Ireland. http:\/\/www.ncri.ie\/news\/article\/hpv-associated-cancers-ireland-report-national-cancer-registry"},{"key":"4866_CR8","unstructured":"European Public Assessment Report for Gardasil -EMEA\/H\/C\/000703 (2017) European Medicines Agency. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp. Accessed 31 July 2017"},{"key":"4866_CR9","unstructured":"European Public Assessment Report for Gardasil 9-EMEA\/H\/C\/003852 (2017) European Medicines Agency. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/003852\/human_med_001863.jsp&mid=WC0b01ac058001d124. Accessed 31 July 2017"},{"key":"4866_CR10","unstructured":"European Public Assessment Report for Cervarix-EMEA\/H\/C\/000721 (2017) European Medicines Agency. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000721\/human_med_000694.jsp&mid=WC0b01ac058001d124. Accessed 31 July 2017"},{"issue":"5","key":"4866_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s1473-3099(14)71073-4","volume":"15","author":"M Drolet","year":"2015","unstructured":"Drolet M, B\u00e9nard \u00c9, Boily MC, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton JML, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV, Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C, Brisson M (2015) Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 15(5):565\u2013580. https:\/\/doi.org\/10.1016\/s1473-3099(14)71073-4","journal-title":"Lancet Infect Dis"},{"issue":"9686","key":"4866_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, Group HPS (2009) Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374(9686):301\u2013314. https:\/\/doi.org\/10.1016\/S0140-6736(09)61248-4","journal-title":"Lancet"},{"issue":"10","key":"4866_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malagon","year":"2012","unstructured":"Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M (2012) Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12(10):781\u2013789. https:\/\/doi.org\/10.1016\/S1473-3099(12)70187-1","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"4866_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens\u2013Part B: biological agents. Lancet Oncol 10(4):321\u2013322","journal-title":"Lancet Oncol"},{"issue":"12","key":"4866_CR15","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202(12):1789\u20131799. https:\/\/doi.org\/10.1086\/657321","journal-title":"J Infect Dis"},{"issue":"6","key":"4866_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/OLQ.0b013e3181c94a3b","volume":"37","author":"AR Kreimer","year":"2010","unstructured":"Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR (2010) Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37(6):386\u2013391. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181c94a3b","journal-title":"Sex Transm Dis"},{"issue":"7","key":"4866_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jama.2012.101","volume":"307","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK (2012) Prevalence of oral HPV infection in the United States, 2009\u20132010. JAMA 307(7):693\u2013703. https:\/\/doi.org\/10.1001\/jama.2012.101","journal-title":"JAMA"},{"issue":"Suppl 5","key":"4866_CR18","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","volume":"30","author":"D Forman","year":"2012","unstructured":"Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S (2012) Global burden of human papillomavirus and related diseases. Vaccine 30 Suppl 5:F12\u2013F23. https:\/\/doi.org\/10.1016\/j.vaccine.2012.07.055","journal-title":"Vaccine"},{"issue":"11","key":"4866_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S Sanjose de","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX, Retrospective International S, Group HPVTTS. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048\u20131056. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8","journal-title":"Lancet Oncol"},{"key":"4866_CR20","unstructured":"Human Papillomavirus (HPV) Vaccine Information (2017) Health service executive. http:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/schoolprog\/hpv\/. Accessed 12 Aug 2017"},{"key":"4866_CR21","unstructured":"HPV Vaccination Patient Information Leaflet for Men who have Sex with Men (MSM) (2017) Health service executive. http:\/\/www.crisispregnancy.ie\/wp-content\/uploads\/2016\/09\/HPV-Vaccine-Patient-Information-Leaflet-MSM-7Nov2016.pdf. Accessed 12 Aug 2017"},{"key":"4866_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-11-13","volume":"11","author":"B Lu","year":"2011","unstructured":"Lu B, Kumar A, Castellsague X, Giuliano AR (2011) Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis 11:13. https:\/\/doi.org\/10.1186\/1471-2334-11-13","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4866_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D (2011) Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 364(5):401\u2013411. https:\/\/doi.org\/10.1056\/NEJMoa0909537","journal-title":"N Engl J Med"},{"key":"4866_CR24","doi-asserted-by":"publisher","unstructured":"Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder S, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint W, Jimenez S, Safaeian M, Struijk L, Schussler J, Hildesheim A, Gonzalez P (2016) Multisite HPV16\/18 vaccine efficacy against cervical, anal, and oral HPV infection. J Natl Cancer Inst 108 (1). https:\/\/doi.org\/10.1093\/jnci\/djv302","DOI":"10.1093\/jnci\/djv302"},{"issue":"Suppl 5","key":"4866_CR25","doi-asserted-by":"publisher","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","volume":"30","author":"LE Markowitz","year":"2012","unstructured":"Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM (2012) Human papillomavirus vaccine introduction\u2014the first five years. Vaccine 30 Suppl 5:F139\u2013F148. https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.039","journal-title":"Vaccine"},{"issue":"30","key":"4866_CR26","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1016\/j.vaccine.2010.04.070","volume":"28","author":"P Bonanni","year":"2010","unstructured":"Bonanni P, Cohet C, Kjaer SK, Latham NB, Lambert PH, Reisinger K, Haupt RM (2010) A summary of the post-licensure surveillance initiatives for GARDASIL\/SILGARD. Vaccine 28(30):4719\u20134730. https:\/\/doi.org\/10.1016\/j.vaccine.2010.04.070","journal-title":"Vaccine"},{"issue":"9783","key":"4866_CR27","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/s0140-6736(11)60551-5","volume":"377","author":"JM Brotherton","year":"2011","unstructured":"Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377(9783):2085\u20132092. https:\/\/doi.org\/10.1016\/s0140-6736(11)60551-5","journal-title":"Lancet"},{"issue":"11","key":"4866_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/olq.0000000000000030","volume":"40","author":"IA Korostil","year":"2013","unstructured":"Korostil IA, Ali H, Guy RJ, Donovan B, Law MG, Regan DG (2013) Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Sex Transm Dis 40(11):833\u2013835. https:\/\/doi.org\/10.1097\/olq.0000000000000030","journal-title":"Sex Transm Dis"},{"issue":"6","key":"4866_CR29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/21645515.2016.1172754","volume":"12","author":"Z Wangu","year":"2016","unstructured":"Wangu Z, Hsu KK (2016) Impact of HPV vaccination on anogenital warts and respiratory papillomatosis. Hum Vaccin Immunother 12(6):1357\u20131362. https:\/\/doi.org\/10.1080\/21645515.2016.1172754","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 5","key":"4866_CR30","doi-asserted-by":"publisher","first-page":"F34","DOI":"10.1016\/j.vaccine.2012.05.070","volume":"30","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsague X (2012) Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 30 Suppl 5:F34\u2013F54. https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.070","journal-title":"Vaccine"},{"issue":"5","key":"4866_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/coa.12565","volume":"41","author":"MR San Giorgi","year":"2016","unstructured":"San Giorgi MR, van den Heuvel ER, Tjon Pian Gi RE, Brunings JW, Chirila M, Friedrich G, Golusinski W, Graupp M, Horcasitas Pous RA, Ilmarinen T, Jackowska J, Koelmel JC, Ferran Vila F, Weichbold V, Wierzbicka M, Dikkers FG (2016) Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol 41(5):448\u2013453. https:\/\/doi.org\/10.1111\/coa.12565","journal-title":"Clin Otolaryngol"},{"key":"4866_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix498","author":"D Novakovic","year":"2017","unstructured":"Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowitz R, Harrison H, Black R, Perry C, Vijayasekaran S, Wabnitz D, Burns H, Tabrizi SN, Garland SM, Elliott E, Brotherton JML (2017) A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jix498","journal-title":"J Infect Dis"},{"issue":"2","key":"4866_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jvoice.2014.08.003","volume":"29","author":"DL Young","year":"2015","unstructured":"Young DL, Moore MM, Halstead LA (2015) The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. J Voice: Off J Voice Found 29(2):223\u2013229. https:\/\/doi.org\/10.1016\/j.jvoice.2014.08.003","journal-title":"J Voice: Off J Voice Found"},{"issue":"6","key":"4866_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/odi.12562","volume":"23","author":"G Prue","year":"2017","unstructured":"Prue G, Lawler M, Baker P, Warnakulasuriya S (2017) Human papillomavirus (HPV): making the case for \u2018Immunisation for All\u2019. Oral Dis 23(6):726\u2013730. https:\/\/doi.org\/10.1111\/odi.12562","journal-title":"Oral Dis"},{"key":"4866_CR35","doi-asserted-by":"publisher","first-page":"c2512","DOI":"10.1136\/bmj.c2512","volume":"340","author":"EJ Junor","year":"2010","unstructured":"Junor EJ, Kerr GR, Brewster DH (2010) Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men. BMJ 340:c2512. https:\/\/doi.org\/10.1136\/bmj.c2512","journal-title":"BMJ"},{"issue":"3","key":"4866_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/0194599814538605","volume":"151","author":"DG Deschler","year":"2014","unstructured":"Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB (2014) The \u201cnew\u201d head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 151 (3):375\u2013380. https:\/\/doi.org\/10.1177\/0194599814538605","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"32","key":"4866_CR37","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294\u20134301. https:\/\/doi.org\/10.1200\/JCO.2011.36.4596","journal-title":"J Clin Oncol"},{"issue":"19","key":"4866_CR38","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","volume":"356","author":"G D\u2019Souza","year":"2007","unstructured":"D\u2019Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case\u2013control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356(19):1944\u20131956. https:\/\/doi.org\/10.1056\/NEJMoa065497","journal-title":"N Engl J Med"},{"issue":"3","key":"4866_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ijc.28201","volume":"134","author":"ML Gillison","year":"2014","unstructured":"Gillison ML, Castellsague X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi S (2014) Eurogin roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer 134(3):497\u2013507. https:\/\/doi.org\/10.1002\/ijc.28201","journal-title":"Int J Cancer"},{"issue":"9","key":"4866_CR40","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3201\/eid1809.111731","volume":"18","author":"J Du","year":"2012","unstructured":"Du J, Nordfors C, Ahrlund-Richter A, Sobkowiak M, Romanitan M, Nasman A, Andersson S, Ramqvist T, Dalianis T (2012) Prevalence of oral human papillomavirus infection among youth. Swed Emerg Infecti Dis 18(9):1468\u20131471. https:\/\/doi.org\/10.3201\/eid1809.111731","journal-title":"Swed Emerg Infecti Dis"},{"issue":"4","key":"4866_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/bjc.2015.462","volume":"114","author":"A Handisurya","year":"2016","unstructured":"Handisurya A, Schellenbacher C, Haitel A, Senger T, Kirnbauer R (2016) Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids. Br J Cancer 114(4):409\u2013416. https:\/\/doi.org\/10.1038\/bjc.2015.462","journal-title":"Br J Cancer"},{"issue":"1","key":"4866_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/00365548.2014.964764","volume":"47","author":"N Grun","year":"2015","unstructured":"Grun N, Ahrlund-Richter A, Franzen J, Mirzaie L, Marions L, Ramqvist T, Dalianis T (2015) Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013\u20132014 after gradual introduction of public HPV vaccination. Inf Dis (London England) 47(1):57\u201361. https:\/\/doi.org\/10.3109\/00365548.2014.964764","journal-title":"Inf Dis (London England)"},{"issue":"7","key":"4866_CR43","doi-asserted-by":"publisher","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","volume":"8","author":"R Herrero","year":"2013","unstructured":"Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PloS One 8(7):e68329. https:\/\/doi.org\/10.1371\/journal.pone.0068329","journal-title":"PloS One"},{"key":"4866_CR44","unstructured":"VFC Program. Centers for disease control and prevention. https:\/\/www.cdc.gov\/features\/vfcprogram\/. Accessed 12 Aug 2016"},{"issue":"12","key":"4866_CR45","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.oraloncology.2015.10.011","volume":"51","author":"RP Takes","year":"2015","unstructured":"Takes RP, Wierzbicka M, D\u2019Souza G, Jackowska J, Silver CE, Rodrigo JP, Dikkers FG, Olsen KD, Rinaldo A, Brakenhoff RH, Ferlito A (2015) HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs? Oral oncology 51(12):1057\u20131060. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.10.011","journal-title":"Oral oncology"},{"key":"4866_CR46","unstructured":"HPV Vaccine Coverage Maps-Inforgraphic (2016) Centers for disease control and prevention. https:\/\/www.cdc.gov\/hpv\/infographics\/vacc-coverage.html. Accessed 12 Aug 2017"},{"key":"4866_CR47","unstructured":"HPV Vaccine Uptake in Ireland: 2015\/2016 (2017) Health service executive. \nhttps:\/\/www.hpsc.ie\/a-z\/vaccinepreventable\/vaccination\/immunisationuptakestatistics\/hpvimmunisationuptakestatistics\/File,16039,en.pdf\n\n. Accessed 12 Aug 2017"},{"issue":"14","key":"4866_CR48","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0264-410X(97)00068-6","volume":"15","author":"M Bottiger","year":"1997","unstructured":"Bottiger M, Forsgren M (1997) Twenty years\u2019 experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination. Vaccine 15(14):1538\u20131544","journal-title":"Vaccine"},{"key":"4866_CR49","doi-asserted-by":"publisher","first-page":"h2016","DOI":"10.1136\/bmj.h2016","volume":"350","author":"JA Bogaards","year":"2015","unstructured":"Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J (2015) Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. Bmj 350:h2016. https:\/\/doi.org\/10.1136\/bmj.h2016","journal-title":"Bmj"},{"issue":"11","key":"4866_CR50","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/cncr.29111","volume":"121","author":"DM Graham","year":"2015","unstructured":"Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS (2015) A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer 121(11):1785\u20131792. https:\/\/doi.org\/10.1002\/cncr.29111","journal-title":"Cancer"},{"key":"4866_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2407-13-10","volume":"13","author":"R Marty","year":"2013","unstructured":"Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J (2013) Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 13:10. https:\/\/doi.org\/10.1186\/1471-2407-13-10","journal-title":"BMC Cancer"},{"issue":"2","key":"4866_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.gyobfe.2006.12.010","volume":"35","author":"J Monsonego","year":"2007","unstructured":"Monsonego J, Breugelmans JG, Bouee S, Lafuma A, Benard S, Remy V (2007) [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]. Gynecol Obstet Fertil 35(2):107\u2013113. https:\/\/doi.org\/10.1016\/j.gyobfe.2006.12.010","journal-title":"Gynecol Obstet Fertil"},{"key":"4866_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13027-017-0129-6","volume":"12","author":"S Hartwig","year":"2017","unstructured":"Hartwig S, St Guily JL, Dominiak-Felden G, Alemany L, de Sanjose S (2017) Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe. Infect Agent Cancer 12:19. https:\/\/doi.org\/10.1186\/s13027-017-0129-6","journal-title":"Infect Agent Cancer"},{"key":"4866_CR54","unstructured":"Statistics by cancer type (2017) Cancer research UK. http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type. Accessed 15 Aug 2017"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-018-4866-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-4866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-018-4866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T07:36:26Z","timestamp":1520235386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-018-4866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4866"],"URL":"https:\/\/doi.org\/10.1007\/s00405-018-4866-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}